Plataforma BIOBADASER III

Registro Español de Acontecimientos Adversos de Terapias Dirigidas en Enfermedades Reumáticas

Biobadaser Fase III

Do Smoking and Obesity Impact Secukinumab Treatment Outcomes? Real-world data from 1,202 European Patients with Psoriatic Arthritis

02/12/2024

Ahmadzay Z, Georgiadis S, Ostergaard M, Glintborg B, Møller-Bisgaard S, Pons M, Heberg J, Christiansen S, Rasmussen S, Loft A, Castrejon I, Otero-Varela L, Závada J, Pavelka K, Rutanen J, Kuusalo L, Nissen M, Rotar Z, Perdan-Pikmajer K, Bernardes M, Gudbjornsson B, Gröndal G, van der Horst-Bruinsma I, Laas K, Michelsen B, Codreanu C, DiGuiseppe D, Moeller B, Kenar G, Hetland M, Oernbjerg L

ACR 2024

https://acrabstracts.org/abstract/do-smoking-and-obesity-impact-secukinumab-treatment-outcomes-real-world-data-from-1202-european-patients-with-psoriatic-arthritis/